Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Proteomics and phosphoproteomics of PDAC

ABSTRACT: Proteomics and phosphoproteomics analysis of PDAC.

INSTRUMENT(S): QE-HF

ORGANISM(S): Homo Sapiens (ncbitaxon:9606)

SUBMITTER: Juntuo Zhou

PROVIDER: MSV000085710 | MassIVE | Fri Jul 10 07:23:00 BST 2020

REPOSITORIES: MassIVE

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

PDAC Proteomics After Neoadjuvant Therapy

Project description:Shotgun Proteomics, Proteomic characterization of the residual PDAC tumor mass after neoadjuvant chemo or combined chemo-radiation therapy

| EGAD00010002388 | EGA

Phosphoproteomics

Project description:Phosphoproteomics

| OEX00028406 | NODE

Multi-level proteomics profiling of virus restrictive and -permissive cellular environments reveal regulatory factors of virus infection

Project description:Virus proliferation inside host cells relies on a diverse range of host machineries and is also restricted by the host through antiviral factors. The configuration of virus-dependency and antiviral factors determine the permissiveness of host cells to virus infection, however, overall differences between highly permissive and restrictive cellular states remain largely unexplored. Here we employed integrated omics analysis combining RNA-seq, proteomics, and phosphoproteomics to study determinants of virus permissiveness on a model system comprising multiple cellular states: highly permissive cells (HEK293T), steady-state cells (HEK293), and restrictive cells (interferon alpha (IFN-a) stimulated HEK293) due to their similar genetic background and distinct permissiveness. Our in-depth proteomics map across cellular states revealed pathway-level depletion of innate immune response and enrichment of anabolic processes in HEK293T cell. RNA-seq and proteomics results depicted dynamic regulations of IFN-α response across early/late timepoints, highlighting a group of robustly upregulated antiviral factors. In addition, phosphoproteomics uncovered extensive alterations of phosphorylation in IFN-a response. Integrated analysis of multi-level omics results identified putative regulators of infection, and we experimentally validated their roles in virus infection.

2024-05-20 | GSE267610 | GEO

Proteomics

Project description:Proteomics

| OEX00019159 | NODE

Proteomics

Project description:Proteomics

| OEX00028405 | NODE

Proteomics

Project description:Proteomics

| OEX00029350 | NODE

Proteomics profiling of sera from normoglycaemic twins for which the body mass index is known

Project description:Bead-based proteomics MolPAGE study using sera from normoglycaemic twins

2008-11-02 | E-TABM-370 | biostudies-arrayexpress

Phosphoproteomics identifies microglial Siglec-F inflammatory response during neurodegeneration

Project description:Phosphoproteomics identifies microglial Siglec-F inflammatory response during neurodegeneration

| PRJNA627466 | ENA

Discovery of a selective inhibitor of Doublecortin Like Kinase 1

Project description:Doublecortin like kinase 1 (DCLK1) is an understudied kinase that is upregulated in a wide range of cancers, including pancreatic ductal adenocarcinoma (PDAC). However, little is known about its potential as a therapeutic target. We leveraged chemoproteomic profiling and structure-based design to develop the first selective, in vivo-compatible chemical probe of the DCLK1 kinase domain, DCLK1-IN-1. We demonstrate activity of DCLK1-IN-1 against clinically relevant patient-derived PDAC organoid models and use a combination of RNA sequencing, proteomics and phosphoproteomics analysis to reveal that DCLK1 inhibition modulates proteins and pathways associated with cell motility in this context. DCLK1-IN-1 will serve as a versatile tool to investigate DCLK1 biology and establish its role in cancer.

2020-04-06 | GSE140490 | GEO

Gene Expression Analysis of PDAC tumors

Project description:Analysis of myofibroblast ablation at the gene expression level of PDAC tumors. Total RNA optained from pancreas of PDAC mice with and without aSMA myofibroblast ablated In addition, late stage aSMA ablated mice were treated with anti-CTLA4 treatment

2015-01-20 | E-GEOD-52812 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data